BioSpace News Archive

Drug Development

AbbVie’s MAVYRET™ (glecaprevir/pibrentasvir) Shows High Virologic Cure* Rates in Treatment-Naïve Hepatitis C Patients with Compensated Cirrhosis

EXPEDITION-8 is the first Phase 3b study evaluating 8 weeks of MAVYRET™ in treatment-naïve chronic hepatitis C virus (HCV)-infected patients with compensated cirrhosis across all major genotypes (GT1-6)[1]

November 13, 2018
·
8 min read
Drug Development

Phase 2 Data for Galmed Pharmaceutical’s Aramchol™ in Non-Alcoholic Steatohepatitis (NASH) Presented During Late-Breaking Abstract Oral Session of The Liver Meeting® 2018

The Phase 2b data has identified Aramchol 600mg as potentially effective to resolve NASH and improve fibrosis

November 13, 2018
·
7 min read
Genetown

Agenus to Present at the 2018 Jefferies London Healthcare Conference

Agenus Inc. announced today that Dr. Jennifer Buell, Chief External Affairs Officer at Agenus, will make a presentation and host one-on-one meetings with investors at the 2018 Jefferies London Healthcare Conference in London, UK.

November 13, 2018
·
2 min read
Biotech Bay

Omada Program for Underserved Participants Delivers Strong Results

Study of Adapted Omada Program Demonstrates Strong Engagement and Weight Loss

November 13, 2018
·
4 min read
Pharm Country

Scientific Leader Launches New Center for Computational and Genomic Medicine

CHOP Program to Focus on Immunotherapy, Other Data-Driven Medical Advances

November 13, 2018
·
4 min read
Business

International Isotopes Inc. Announces a Long-Term Supply Agreement For I-131 With The University Of Missouri Research Reactor

INIS Will Utilize The Sole Domestic Producer As One Of Their Principal Suppliers Of This Important Isotope

November 13, 2018
·
3 min read
Genetown

Enanta Announces that AbbVie’s MAVYRET™ (glecaprevir/pibrentasvir) Shows High Virologic Cure* Rates in Treatment-Naïve Hepatitis C Patients with Compensated Cirrhosis

EXPEDITION-8 is the first Phase 3b study evaluating 8 weeks of MAVYRET™ in treatment-naïve chronic hepatitis C virus (HCV)-infected patients with compensated cirrhosis across all major genotypes (GT1-6)1

November 13, 2018
·
9 min read
Royal DSM to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on November 14, 2018

Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual event

November 13, 2018
·
2 min read
BioInvent Announces Publication of Data in Leading Cancer Journal Immunity

Interactions with Fc gamma receptors determine efficacy and mechanism-of-action of co-stimulatory checkpoint antibodies

November 13, 2018
·
5 min read
Job Trends

Expanding Applications of NX Prenatal’s Exosome-Based Diagnostics Platform Presented at Key Conferences

NX Prenatal Inc. announced today that expanding applications of its proprietary NeXosome® liquid biopsy platform were presented at recent scientific conferences.

November 13, 2018
·
2 min read